Photo courtesy of UC San Diego/ Erik Jepsen.
CEO Patrik Schmidle standing in the Qualcomm Institute Innovation Space at UC San Diego.

Photo courtesy of UC San Diego/ Erik Jepsen. CEO Patrik Schmidle standing in the Qualcomm Institute Innovation Space at UC San Diego.

San Diego-based CARI Therapeutics, a startup that is developing an implantable biosensor that could help combat the opioid crisis, has received additional funding from the National Institute of Drug Abuse (NIDA)...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99